Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Dyax Corp (NQ: DYAX)
2.540 USD  +0.050 (+2.01%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Dyax Corp
 
< Previous 1 2 3 4 5 6 7 8 9 Next >
Dyax HAE Allies? Awards Program Launches on Second Annual Hereditary Angioedema (HAE) Day – a Global Event to Raise Awareness of HAE
May 16, 2013
from Business Wire News Releases
Dyax Announces $30 Million Offering
May 13, 2013
from Business Wire News Releases
PennyStocks.com Announces Trade Alerts on: TALK, LOTE, GSAT, and DYAX
April 29, 2013
NOTE TO EDITORS: The Following Is an Investment Opinion Issued by Equity Spotlight Read More
from Marketwired News Releases
Dyax Corp. to Participate in the Needham Healthcare Conference
April 29, 2013
from Business Wire News Releases
Dyax Corp. Announces First Quarter 2013 Financial Results
April 25, 2013
from Business Wire News Releases
Dyax Corp. to Host First Quarter 2013 Earnings Call and Webcast
April 18, 2013
from Business Wire News Releases
Dyax Corp. to Participate in the 25th Annual ROTH Conference
March 12, 2013
from Business Wire News Releases
Dyax Announces Management Change
March 08, 2013
from Business Wire News Releases
Free Research Reports on APP, DYAX, HIMX and ZOLT Issued by the Bedford Report
March 06, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
March 06, 2013
RDInvesting Provides Stocks Research on Neuralstem and Dyax Read More
from Marketwired News Releases
Dyax Presents DX-2930 Data at the 2013 American Academy of Allergy, Asthma and Immunology Annual Meeting
February 25, 2013
from Business Wire News Releases
Dyax Corp. to Participate in Upcoming 2013 Healthcare Conferences
February 20, 2013
from Business Wire News Releases
Dyax Corp. Announces Fourth Quarter and Full Year 2012 Financial Results
February 13, 2013
from Business Wire News Releases
Dyax Corp. and CVie Therapeutics Announce Partnership to Develop and Commercialize KALBITOR® (ecallantide) for Hereditary Angioedema (HAE) and Other Angioedema Indications in China, Hong Kong and Maca
February 07, 2013
from Business Wire News Releases
Dyax Corp. to Participate in the Leerink Swann Global Healthcare Conference
February 06, 2013
from Business Wire News Releases
Dyax Corp. to Host Fourth Quarter and Year End 2012 Earnings Call and Webcast
February 05, 2013
from Business Wire News Releases
Free Research Report on Dyax Corp., Ebix, Inc., 8x8, Inc., EnerSys and Express Scripts Holding Co.
January 31, 2013
from PR Newswire
Dyax Corp. and Novellus Biopharma AG Announce Partnership to Develop and Commercialize KALBITOR® (ecallantide) for Hereditary Angioedema (HAE) and Other Angioedema Indications in Latin America
January 31, 2013
from Business Wire News Releases
Behind The Success - Research Report on Corcept Therapeutics Inc. and Dyax Corp.
January 23, 2013
Biotech firms Corcept and Dyax have each risen to the occasion with their innovative solutions for unmet medical needs, both having gained substantial momentum as of late Read More
from PR Newswire
Dyax Corp. Announces Presentation of KALBITOR® (ecallantide) Pediatric and Abdominal Attack Data at the American College of Allergy, Asthma and Immunology Annual Meeting (ACAAI)
November 13, 2012
from Business Wire News Releases
Dyax Corp. to Participate in November 2012 Healthcare Conferences
November 07, 2012
from Business Wire News Releases
Dyax Corp. Announces Third Quarter 2012 Financial Results
October 24, 2012
from Business Wire News Releases
Dyax Corp. to Host Third Quarter 2012 Earnings Call and Webcast
October 17, 2012
from Business Wire News Releases
Dyax Corp. Appoints Marc Kozin to Board of Directors
October 16, 2012
from Business Wire News Releases
Dyax Corp. and Kadmon Sign Strategic Licensing Agreement for DX-2400
September 20, 2012
from Business Wire News Releases
Dyax Corp. to Participate in the UBS Global Life Sciences Conference
September 13, 2012
from Business Wire News Releases
Dyax Corp. to Participate in the Rodman & Renshaw Annual Global Investment Conference
August 30, 2012
from Business Wire News Releases
Dyax Corp. Creates COO Position and Expands Executive Roles
August 20, 2012
from Business Wire News Releases
Dyax Corp. Announces Second Quarter 2012 Financial Results
July 19, 2012
from Business Wire News Releases
Dyax Corp. to Host Second Quarter 2012 Earnings Call and Webcast
June 28, 2012
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here